David Edward Johnson - Net Worth and Insider Trading
David Edward Johnson Net Worth
The estimated net worth of David Edward Johnson is at least $52 Million dollars as of 2024-12-26. David Edward Johnson is the Director of Exelixis Inc and owns about 1,543,906 shares of Exelixis Inc (EXEL) stock worth over $52 Million. Details can be seen in David Edward Johnson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Edward Johnson has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Edward Johnson
David Edward Johnson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Edward Johnson owns 5 companies in total, including AMAG Pharmaceuticals Inc (AMAG) , Standard BioTools Inc (LAB) , and Liquidia Corp (LQDA) among others .
Click here to see the complete history of David Edward Johnson’s form 4 insider trades.
Insider Ownership Summary of David Edward Johnson
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AMAG | AMAG Pharmaceuticals Inc | 2020-06-02 | director & 10 percent owner |
| LAB | Standard BioTools Inc | 2021-05-07 | 10 percent owner |
| LQDA | Liquidia Corp | 2021-04-12 | 10 percent owner |
 | | 2024-05-30 | director |
| | 2023-08-01 | 10 percent owner |
David Edward Johnson Latest Holdings Summary
David Edward Johnson currently owns a total of 1 stock. David Edward Johnson owns 1,543,906 shares of Exelixis Inc (EXEL) as of May 30, 2024, with a value of $52 Million.
Latest Holdings of David Edward Johnson
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EXEL | Exelixis Inc | 2024-05-30 | 1,543,906 | 33.82 | 52,214,901 |
Holding Weightings of David Edward Johnson
David Edward Johnson Form 4 Trading Tracker
According to the SEC Form 4 filings, David Edward Johnson has made a total of 4 transactions in Exelixis Inc (EXEL) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Exelixis Inc is the acquisition of 425,000 shares on May 30, 2024, which cost David Edward Johnson around $9 Million.
Insider Trading History of David Edward Johnson
- 1
David Edward Johnson Trading Performance
GuruFocus tracks the stock performance after each of David Edward Johnson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Edward Johnson is 9.06%. GuruFocus also compares David Edward Johnson's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Edward Johnson within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Edward Johnson's insider trading performs compared to the benchmark.
Performance of David Edward Johnson
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 11.62 | | | | | |
| Relative Return to S&P 500(%) | 6.76 | | | | | |
David Edward Johnson Ownership Network
David Edward Johnson Owned Company Details
What does AMAG Pharmaceuticals Inc do?
Who are the key executives at AMAG Pharmaceuticals Inc?
David Edward Johnson is the director & 10 percent owner of AMAG Pharmaceuticals Inc. Other key executives at AMAG Pharmaceuticals Inc include 10 percent owner Camber Capital Management Lp , Chief Operating Officer Anthony Casciano , and Interim CFO Brian Piekos .
AMAG Pharmaceuticals Inc (AMAG) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc (AMAG) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc (AMAG) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
AMAG Pharmaceuticals Inc (AMAG)'s detailed insider trading history can be found in Insider Trading Tracker table.
AMAG Pharmaceuticals Inc Insider Transactions
David Edward Johnson Mailing Address
Above is the net worth, insider trading, and ownership report for David Edward Johnson. You might contact David Edward Johnson via mailing address: 590 Madison Avenue, New York Ny 10022.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
